Literature DB >> 21957290

Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages.

Fransje A Koning1, Caroline Goujon, Hélène Bauby, Michael H Malim.   

Abstract

Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins are encapsidated by assembling HIV-1 virions and edit viral cDNA in the next round of infection. Using alpha interferon (IFN-α)-treated monocyte-derived macrophages, we show that infrequent editing of HIV-1 reverse transcripts can also be mediated by APOBEC3 proteins supplied by the targets of infection. Based on the local sequence contexts of these mutations and the established characteristics of APOBEC3 protein expression in myeloid cells, we speculate that APOBEC3A may be responsible for a substantial proportion of this activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957290      PMCID: PMC3233168          DOI: 10.1128/JVI.00775-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.

Authors:  Shari M Kaiser; Michael Emerman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.

Authors:  Yannick Bulliard; Iñigo Narvaiza; Alessandro Bertero; Shyam Peddi; Ute F Röhrig; Millán Ortiz; Vincent Zoete; Nataly Castro-Díaz; Priscilla Turelli; Amalio Telenti; Olivier Michielin; Matthew D Weitzman; Didier Trono
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue.

Authors:  Gilad Doitsh; Marielle Cavrois; Kara G Lassen; Orlando Zepeda; Zhiyuan Yang; Mario L Santiago; Andrew M Hebbeler; Warner C Greene
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

4.  Flexible use of nuclear import pathways by HIV-1.

Authors:  KyeongEun Lee; Zandrea Ambrose; Thomas D Martin; Ilker Oztop; Alok Mulky; John G Julias; Nick Vandegraaff; Joerg G Baumann; Rui Wang; Wendy Yuen; Taichiro Takemura; Kenneth Shelton; Ichiro Taniuchi; Yuan Li; Joseph Sodroski; Dan R Littman; John M Coffin; Stephen H Hughes; Derya Unutmaz; Alan Engelman; Vineet N KewalRamani
Journal:  Cell Host Microbe       Date:  2010-03-18       Impact factor: 21.023

5.  Widespread RNA and DNA sequence differences in the human transcriptome.

Authors:  Mingyao Li; Isabel X Wang; Yun Li; Alan Bruzel; Allison L Richards; Jonathan M Toung; Vivian G Cheung
Journal:  Science       Date:  2011-05-19       Impact factor: 47.728

Review 6.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Authors:  John S Albin; Reuben S Harris
Journal:  Expert Rev Mol Med       Date:  2010-01-22       Impact factor: 5.600

Review 7.  APOBEC proteins and intrinsic resistance to HIV-1 infection.

Authors:  Michael H Malim
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

8.  The SET complex acts as a barrier to autointegration of HIV-1.

Authors:  Nan Yan; Peter Cherepanov; Janet E Daigle; Alan Engelman; Judy Lieberman
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

9.  APOBEC3 proteins mediate the clearance of foreign DNA from human cells.

Authors:  Mark D Stenglein; Michael B Burns; Ming Li; Joy Lengyel; Reuben S Harris
Journal:  Nat Struct Mol Biol       Date:  2010-01-10       Impact factor: 15.369

Review 10.  The population genetics and evolutionary epidemiology of RNA viruses.

Authors:  Andrés Moya; Edward C Holmes; Fernando González-Candelas
Journal:  Nat Rev Microbiol       Date:  2004-04       Impact factor: 60.633

View more
  36 in total

1.  Variation of HIV-1 mutation spectra among cell types.

Authors:  Colleen M Holtz; Louis M Mansky
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

2.  Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

Authors:  Allison M Land; Emily K Law; Michael A Carpenter; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

Review 3.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

4.  Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain.

Authors:  Miki Katuwal; Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Kalani Halemano; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2014-09-28       Impact factor: 3.616

5.  Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor.

Authors:  Spyridon Stavrou; Wenming Zhao; Kristin Blouch; Susan R Ross
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

6.  Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.

Authors:  Robin P Love; Huixin Xu; Linda Chelico
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

7.  APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.

Authors:  Alyssa L MacMillan; Rahul M Kohli; Susan R Ross
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

8.  Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.

Authors:  Kieran Gillick; Darja Pollpeter; Prabhjeet Phalora; Eun-Young Kim; Steven M Wolinsky; Michael H Malim
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.

Authors:  Spyridon Stavrou; Takayuki Nitta; Swathi Kotla; Dat Ha; Kunio Nagashima; Alan R Rein; Hung Fan; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

10.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.